The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League

Nav

General Info

Geography

Germany (DEU)

Time period covered

01/2000 - 12/2003

Data type

Scientific literature

Keywords

Ischemic heart disease, Intracerebral hemorrhage, Subarachnoid hemorrhage, Ischemic stroke, Blood pressure

Citation

Authors

Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO Study Group

Journal

J Hypertens

Volume

Issue

Pages

1487–96

Publication year

2008

Suggested citation

Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO Study Group. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens. 2008; 26(7): 1487–96.

GHDx Entry last modified on: Oct 8, 2022

Header sites

Search form

Main menu

The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League

Nav